Novo Holdings

Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's

Holding Company Active Hellerup, Denmark Est. 1999
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$14.8M
total disclosed, rounds participated
Stages
A Round, D Round, Seed, G Round, E Round, Pre-Seed, F Round, C Round, B Round

About

Novo Holdings, the primary shareholder of Novo Nordisk A/S and Novozymes A/S, manages a substantial investment portfolio with a focus on long-term returns. As the asset management arm of the Novo Nordisk Foundation—one of the world’s largest philanthropic enterprise foundations—Novo Holdings plays a central role in stewarding the Foundation's wealth. In addition to handling a broad mix of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a global leader in life sciences investment. Through its Seeds, Venture, Growth, and Principal Investments teams, the company supports life science companies at every stage of development

Portfolio · 1

HPNow
Hydrogen Peroxide Generation Solutions
1 round $14.8M committed Latest: 2023-09

Investment activity

Portfolio by sector

Agriculture & Food Technologies1
Health Tech & Life Sciences1

Q&A

What is Novo Holdings' primary focus as an investment firm?
Novo Holdings is the wholly owned holding company of the Novo Nordisk Foundation, primarily managing its substantial investment portfolio with a focus on long-term returns. It is a global leader in life sciences investment, supporting companies at every stage of development.
What types of investment stages does Novo Holdings participate in?
Novo Holdings participates in a broad range of investment stages, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Can you name some of Novo Holdings' recent portfolio companies?
Novo Holdings has recently invested in HPNow, a company focused on Hydrogen Peroxide Generation Solutions, and Magenta Medical, which specializes in Self-Expanding Percutaneous Mechanical Circulatory Support.
What is Novo Holdings' investment range?
Novo Holdings' investment range is between $14.84 million and $105 million.
Which sectors does Novo Holdings primarily invest in?
Novo Holdings shows a concentration in the Agriculture & Food Technologies sector and the Health Tech & Life Sciences sector, with one investment round in each.
When was Novo Holdings founded?
Novo Holdings was established in 1999.
What was Novo Holdings' most recent investment activity?
Novo Holdings made an investment in July 2024, adding a new portfolio company.
Can you describe a notable investment made by Novo Holdings in the Health Tech sector?
In July 2024, Novo Holdings participated in an E Round for Magenta Medical, a company developing Self-Expanding Percutaneous Mechanical Circulatory Support, which raised $224.9 million.
What is a notable investment by Novo Holdings in the Agriculture & Food Technologies sector?
In September 2023, Novo Holdings invested in HPNow, a company that provides Hydrogen Peroxide Generation Solutions, as part of its C Round, which raised $28.53 million.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)